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Previewscritical to develop nonviral, genome non-
integrating conversion methods such as
direct protein delivery (Kim et al., 2009).REFERENCES
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The forkhead box O (FoxO) family is involved in diverse cellular processes such as tumor suppression, stress
response, and metabolism. In a recent Nature Cell Biology Letter, Zhang et al. (2011) uncover a novel role for
FoxO proteins in regulating the identity of human ESCs.Embryonic stem cells (ESCs) are distin-
guished by the features of pluripotency
(the ability to give rise to all cell types in
and derived from the embryo proper) and
self-renewal (the capability to be grown
indefinitely in an undifferentiated state
in vitro). This unique ESC state is defined
by a distinct gene expression profile
crafted by the ESC transcription network,
wherein the trio of OCT4, SOX2, and
NANOG lies at the core (reviewed in
Young, 2011). The ESC state is nonethe-
less sustainedbymanyother transcription
factors, establishing an integrated tran-
scription network,which,whenperturbed,
triggers the loss of ESC identity.
The extended pluripotency network
includesnumerous familiesof transcription
factors, including the Kru¨ppel-like tran-
scription factors, orphan nuclear recep-
tors, the Myc transcription factor cluster,
SMAD proteins, and PR domain-contain-
ing transcriptional regulators to highlighta few (reviewed in Gonzales and Ng,
2011). In a recent issue of Nature Cell
Biology, Ghaffari and colleagues (Zhang
et al., 2011) introduce a new component
to this network of pluripotency regulators:
the forkheadboxO (FoxO) family (Figure1).
FoxO proteins are transcription factors
thatactasstress-response tumorsuppres-
sors byblocking cell cycle progression and
inducing apoptosis (reviewed in van den
Berg and Burgering, 2011). FoxO proteins
also induce expression of enzymes
involved in protection fromoxidative stress
and are important for metabolic processes
in liver and muscle cells.
Despite the wide scope of function of
the FoxO family throughout the body, its
role in early embryonic development had
not yet been studied in detail. In this
respect, Ghaffari and colleagues have
found that FOXO1 is expressed at abun-
dant levels in both mouse ESCs (mESCs)
and human ESCs (hESCs) and is depletedduring differentiation (Zhang et al., 2011).
For assessing the functional relevance of
FOXO1 in hESCs, a short hairpin RNA
(shRNA)-mediated knockdown experi-
ment was performed. They observed the
acquisition of an epithelial flattened
morphology accompanied by a loss of
pluripotency markers and an increase in
endomesoderm markers. This phenotype
can be rescued by immediate FOXO1
overexpression, demonstrating the speci-
ficity of the shRNA knockdown. How-
ever, when hESCs were cultured under
FOXO1 knockdown conditions for a few
passages, the rescue did not work.
This finding indicates that FOXO1 deple-
tion can trigger irreversible differentiation
within several passages, emphasizing the
importance of FOXO1 in ESCs.
Interestingly, differences were ob-
served between mouse and human
ESCs in the role of FOXO3A/Foxo3,
another FoxO family member tested ineptember 2, 2011 ª2011 Elsevier Inc. 181
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Figure 1. Models for the Transcriptional Regulatory Network in
Human and Mouse ESCs
(A) In hESCs, FOXO1 directly upregulates OCT4 and SOX2 expression.
(B) Foxo1 and Foxo3 are implicated in the maintenance of the mESC state.
Comprehensive determination of the FoxOs’ target genes in ESCs would
enable a global understanding of their integration into the pluripotency
network, as well as provide new insights into species-specific circuitries.
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mediated Foxo3 depletion,
mESCs underwent differenti-
ation as seen from the de-
crease of pluripotencymarker
levels and an increase in
Cdx2 and Fgf5 expression. In
contrast, neither thedepletion
nor the overexpression of
FOXO3A in hESCs conferred
an observable effect. Thus
despite the conservation of
FoxOs through mammalian
evolution, species-specific
differences are still evident.
This result is reminiscent
of the transcription factor
PRDM14, which is essential
for themaintenance of hESCs
but not mESCs (Chia et al.,
2010). Foxo1 null mice and
Foxo3 null mice do not show
defects in embryonic devel-
opment prior to gastrulation,
a phenomenon also seen in
the knockout of Prdm14 in
mice (Yamaji et al., 2008).
Whereas this pattern is in
line with the species-specific
function of PRDM14 in ESCs,
FoxO’s dispensability in the
mouse’s early embryonic
development is surprising.
Andwhile several possibilities
including redundancy have
been raised, an explanation
for the observed differences
remains to be ascertained.
Redundancy has often been
associated with the FoxOfamily because FoxOs are generally
considered to share targets, with the
specificity of individual members being
determined by their distinct expression
patterns. Therefore, it is especially striking
that Ghaffari and colleagues have shown
that the depletion of Foxo1 and Foxo3
activates distinct sets of differentiation
markers, suggesting divergence between
their target genes. This observed discrim-
ination indicates that the previous para-
digm of redundancy within the FoxO
family might not hold true in the ESC
context.
Ghaffari and colleagues further studied
the control of FoxO activity in hESCs and
observed that FOXO3A ismostly localized
in the cytoplasm. Given that FoxOs are
regulated by common pathways, this182 Cell Stem Cell 9, September 2, 2011 ª20raises the question of why FOXO1 re-
mains in the nucleus unlike FOXO3A.
Localization of FoxO proteins is primarily
governedby the phophoinositide 3-kinase
(PI3K)/AKT pathway, where AKT-medi-
ated phosphorylation of FoxO induces its
nuclear export, thereby preventing it
from exercising its transcriptional activity.
Indeed, when the effect of basic fibroblast
growth factor (bFGF), which acts through
the PI3K/AKT pathway, was examined,
FOXO1 phosphorylation was detected.
This can be inhibited by the PI3K inhibitor
LY294002, confirming that bFGF exerts its
effect on FOXO1 through the PI3K/AKT
pathway. It is thus very intriguing how
FOXO1 is phosphorylated and yet not
exported from the nucleus under hESC
culture conditions in the presence of11 Elsevier Inc.bFGF. It is speculated that
other signaling pathways
such as the JNK pathway
(which overrides AKT at least
for FOXO4) or the PRMT1
pathway (which abrogates
AKTphosphorylationbymeth-
ylation) are responsible for this
phenomenon. Although it
remains to be elucidated
which pathways are actually
involved in the control of
FOXO1 in hESCs, this finding
nevertheless emphasizes that
various pathways act in a
network and their interac-
tion can create unanticipated
outcomes.
Given that FoxOshavebeen
implicated in many different
processes, the differentiation
of hESCs upon FOXO1 deple-
tion could be due to any of
these known functions of the
FoxO family. Ghaffari and
colleagues showedwithmulti-
ple experiments that prolifera-
tion, cell cycle, redox status,
and apoptosis are all unaf-
fected by FOXO1 depletion.
Instead, they revealed a previ-
ously unknown function for
FOXO1. Chromatin immuno-
precipitation and electropho-
retic mobility shift assay ex-
periments demonstrate that
FOXO1directlybinds tospeci-
fic regulatory regions ofOCT4
and SOX2, and luciferase
assays confirm that this bind-ing activates OCT4 and SOX2 expression.
This highlights the context-dependent
roles of pluripotency factors, wherein
they work differently in ESCs and somatic
cells.
The rapid growth of the ESC field in
recent years has led to a much improved
understanding of the regulatory network
that governs pluripotent cells. The inclu-
sion of FoxO into this network brings in
fresh perspectives in the design of
the pluripotency transcriptional circuitry.
For instance, the differences between
murine and human FoxO function high-
light the impact of evolutionary diver-
gence (Figure 1). Genome-wide analysis
of FoxO binding sites will provide
additional insights into the interaction
of FoxOs with the core transcriptional
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Previewsregulatory network defined by the cur-
rently known pluripotency factors (re-
viewed in Young, 2011). Because pluripo-
tency factors are known to be involved
in cellular reprogramming, it is also
worthwhile to test the role of FoxO
proteins in induced pluripotent stem cell
derivation. Finally, recent work has re-
vealed that pluripotency factors play
additional roles in driving differentiation
into specific lineages (Thomson et al.,
2011; discussed in Loh and Lim, 2011);
it would therefore be of interest to analyze
the dynamics of transcriptional regula-
tory networks when ESCs exit the self-renewal state and enter lineage-specific
differentiation.ACKNOWLEDGMENTS
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Chromatinmodifications are important for embryonic stem cell (ESC) pluripotency, but their functions in adult
stem cells are less clear. In this issue of Cell Stem Cell, Lien et al. (2011) delineate histone methylation
patterns in hair follicle stem cells and show that these marks differ from those of ESCs.Histones are subject to numerous modifi-
cations that affect chromatin structure
and alter transcription factor accessibility.
Among these, trimethylation of histone H3
on lysine 4 (H3K4me3) in promoter re-
gions is associated with transcriptional in-
itiation, whereas broadening of H3K4me3
marks and dimethylation of histone H3
at lysine 79 (H3K79me2) characterize ac-
tive transcription. Conversely, trimethyla-
tion of histone H3 lysine 27 (H3K27me3)
marks certain genes that possess low or
absent transcriptional activity (Suganuma
and Workman, 2011).
Histone methylation and demethylation
are carried out by multiprotein complexes
whose components ensure target spe-
cificity, efficiency of modification, and
interactions with other chromatin modi-
fiers and transcription factors. Polycomb
group (PcG) repressive complexes (PRC)
have attracted interest because theyassociate with cell-fate regulators. H3K27
is specifically trimethylated by the PRC2
enzymes EZH1 and EZH2, which ulti-
mately promotes histone H2A ubiqui-
tination, chromatin condensation, and
gene silencing (Suganuma and Workman,
2011).
PRC2 proteins are required for estab-
lishing and maintaining the undifferenti-
ated state and pluripotency of embryonic
stem cells (ESCs) (Fisher and Fisher,
2011). Unexpectedly, genome-wide map-
ping of histone methylation sites revealed
that, in addition to genes marked by
H3K4me3 or H3K27me3, several thou-
sand ‘‘bivalent’’ genes display both
H3K4me3 and H3K27me3 marks in
human and mouse ESC populations. This
gene set is enriched for developmental
regulators that are repressed by pluripo-
tency-associated factors, leading to the
idea that bivalency marks genes as‘‘poised’’ for subsequent transcription or
repression (Fisher and Fisher, 2011).
More recent experiments suggest that
bivalency in ESC populations may reflect
their underlying heterogeneity and plas-
ticity, rather than the existence of both
activating and repressive marks at a given
locus within an individual cell or DNA
strand (Hong et al., 2011). Understanding
the precise nature of bivalency and its
underlying mechanism will likely require
analysis at the single-cell level (De Gobbi
et al., 2011).
Bivalent genes are also detected in
other progenitor populations, including
hematopoietic progenitors, mesenchymal
stem cells, neural progenitor cells (NPCs),
and murine embryonic fibroblasts (MEFs),
where their identities reflect develop-
mental potential; for instance, genes re-
lated to adipogenesis are often bivalent
in MEFs but not in NPCs (Fisher andeptember 2, 2011 ª2011 Elsevier Inc. 183
